Capital Market News Sun Pharmaceuticals Industries announced that the Board of Directors of the Company at its meeting held on 31 January 2023, inter alia, have recommended the interim dividend of Rs 7.5 per equity Share (i.e. 750%) , subject to the approval of the shareholders.